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The Modiﬁed Shuttle Test (MST) is an externally paced, incremental, ﬁeld exercise
test with 15 levels. It has been shown to be a reliable, repeatable and sensitive
measure of exercise capacity in adults with cystic ﬁbrosis (CF). In our clinic,
however, 6% of patients exceed the 15th level of the test. Furthermore, 31% of
age-matched healthy adults exceeded the 15th level. This limits the utility of the
MST as a measure of exercise capacity in studies comparing participants with CF to
healthy control participants. The purpose of this study was to assess the reliability
of the MST with 25 levels (MST-25).
Method: The MST was extended by 10 levels, with the number of shuttles increased
by one at each additional level. 15 participants (10 healthy, 5 CF) performed
the MST-25 on two occasions within one week. All participants were clinically
stable (<10% variation in FEV1 from the best during the previous 6 months). All
participants wore the SenseWear Pro3 Armband (BodyMedia, USA) − a physical
activity monitor that integrates accelerometry and physiological sensors to estimate
energy expenditure. Total step count, Borg Dyspnoea Score and heart rate were
recorded at the end of the test.
Results: There was a signiﬁcant and strong correlation between the two MST-25
test days for distance completed (Pearson’s r = 0.99), SpO2 at peak (r = 0.99), energy
expenditure estimated by the SenseWear Pro3 Armband (r = 0.97), and total step
count (r = 0.97). Correlations were less strong for dyspnoea (r = 0.76) and heart rate
(r = 0.78) at peak exercise.
Discussion: The MST-25 shows good test re-test reliability and can be used for
patients and healthy controls whose peak exceeds the MST. We are now investigating
the sensitivity of the MST-25 to clinical change.
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Objectives: Peak oxygen uptake (VO2peak) derived through maximal cardiopul-
monary exercise testing (CPXT) is impaired in children with Cystic ﬁbrosis (CF),
and is a measure of disease severity. Our aims were to compare the proﬁle of oxygen
uptake (VO2) during recovery following CPXT in children with CF and controls.
Methods: 19 children with CF and 19 controls matched for age, sex and maturity
performed CPXT on a cycle ergometer to exhaustion. Pulmonary gas was measured
continuously by an on-line metabolic gas analyser using a 10 s moving average,
during and for 10 min after CPXT. Following CPXT the fast component of
VO2 falls in an exponential manner that can be mathematically modelled, using
a mono-exponential model including a delay term, with the formula; VO2(t) =
A{1 − exp[−(t − TD)/t]} where; VO2(t) is VO2 at a given time point; A is the
amplitude of the fast component from VO2peak; D is the delay term; t is the time
constant, the time taken to reach 63% of the amplitude of the fast component
of VO2 recovery. Disease severity in the children with CF was quantiﬁed by the
Shwachman score.
Results: VO2peak was reduced in children with CF compared to controls (35±8
versus 44±12mL.kg-1.min−1, P< 0.01). Furthermore, the t was signiﬁcantly longer
in children with CF compared to controls (44.9±9.8 versus 38.5±6.0 s, P< 0.05),
and related to disease severity (r = −0.75, P< 0.01). The t was not signiﬁcantly
correlated with VO2peak in either the children with CF or controls. Therefore, the
t can not be reliably predicted by VO2peak .
Conclusions: The pattern of decline in VO2 during recovery after CPXT differs
between CF and controls and is related to disease severity. Recovery measures may
enhance our objective assessment of exercise impairment in CF.
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The three-minute step test (3MST) is a simple test of exercise capacity which
is commonly used in patients with CF, however there are no data regarding its
prognostic value. This study aims to determine whether performance on the 3MST
is associated with long-term clinical outcomes in adults with CF.
Methods: Clinically stable patients were recruited from the CF outpatient clinic.
The 3MST was conducted following a standardised protocol using a 15cm high step,
external pacing at 30steps/minute and continuous monitoring of SpO2, heart rate and
perceived exertion on the Borg scale. Relationships between baseline performance
on the 3MST and clinical outcomes at 12 months (change in % predicted FEV1
and inpatient hospital days) were assessed.
Results: Data were available for 48 (30 males) of mean age 30 (standard deviation 8)
years, FEV1 64 (25) % predicted and BMI 23 (5) kg.m
−2. Participants who
desaturated to less than 90% on 3MST (n = 12) had a larger number of hospital
days over the following 12 months than those who did not (median 17 days vs
2 days, p = 0.007). Those who desaturated also had and a greater decline in FEV1%
predicted (mean difference 4.9%, 95% conﬁdence interval 0.5−9.3%). Heart rate and
symptom scores on 3MST were not associated with clinical outcome at 12 months.
Conclusions: Performance on the 3MST may be associated longer-term pulmonary
deterioration and increased hospital admission days. Larger samples are required to
conﬁrm the prognostic value of the 3MST in adults with CF.
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Introduction: In patients with cystic ﬁbrosis (CF) exercise capacity is related
to disease severity, nutritional status, lung function, quality of life, morbidity
and mortality. Reference values of maximal oxygen uptake (VO2max) of healthy
children are available however these are unsuitable for CF children as height-for-
age and nutritional status are regularly reduced and onset of puberty is frequently
delayed. CF speciﬁc reference values will give better insights in disease-related
normal deterioration of exercise capacity. Therefore, the aim of the study is to create
disease-speciﬁc reference values for VO2max in relation to age, sex, anthropometric
values and lung function in CF children.
Methods: Data were acquired from a database (1998–2008). VO2max was mea-
sured during CPET. Anthropometric variables are expressed as weight and height
and lung function as the forced expiratory volume in 1 second (FEV1). Data were
analyzed with the GAMLSS method.
Results: 1109 CPET results were used of 277 CF children (146 boys; 131 girls)
with a mean (SD) age of 11.84 (3.63) years, mean (SD) weight of 39.19 (14.64)
kg and mean (SD) length of 147.80 (20.07) cm. FEV1 of predicted ranged from
21 to 151 with a mean (SD) of 89 (20) %. VO2max ranged from 0.30 to 3.80 with
a mean (SD) of 1.66 (0.61) l·min−1. Final reference equations will be presented.
Conclusion: CF-speciﬁc reference equations allow clinicians to compare exercise
capacity of individual patients with those of their peers with CF. This might improve
generalization of future CF clinical trials by setting entry criteria that are equitable
across sex and age ranges. The new reference equations may serve as a useful
adjunct to conventional ones for healthy children.
